FTDZX Holdings Information

FTDZX is a mutual fund with a total of 95 individual holdings. The top holdings are Gilead Sciences stock at 5.78%, Amgen at 5.31%, Jazz Pharmaceuticals at 5.18%, Vertex Pharmaceuticals at 4.89%, and Regeneron Pharmaceuticals at 4.59%.

Total Holdings

Top 10 Percentage

41.24%

Asset Class

Equity

Fund Category

Health

Assets

1.04B

Forward PE Ratio

17.67

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	5.78%	403,148
2	AMGN	Amgen Inc.	5.31%	141,974
3	JAZZ	Jazz Pharmaceuticals plc	5.18%	283,073
4	VRTX	Vertex Pharmaceuticals Incorporated	4.89%	102,150
5	REGN	Regeneron Pharmaceuticals, Inc.	4.59%	61,019
6	ARGX	argenx SE	3.62%	48,962
7	TERN	Terns Pharmaceuticals, Inc.	3.13%	770,542
8	PRAX	Praxis Precision Medicines, Inc.	3.12%	96,221
9	ASND	Ascendis Pharma A/S	2.92%	129,742
10	INSM	Insmed Incorporated	2.71%	188,633
11	PTCT	PTC Therapeutics, Inc.	2.43%	369,527
12	GH	Guardant Health, Inc.	2.25%	248,985
13	EYPT	EyePoint, Inc.	2.15%	1,269,215
14	ALNY	Alnylam Pharmaceuticals, Inc.	2.15%	66,908
15	LON: AZN	AstraZeneca PLC	2.06%	102,531
16	RVMD	Revolution Medicines, Inc.	1.99%	202,430
17	ABVX	ABIVAX Société Anonyme	1.92%	164,591
18	MIRM	Mirum Pharmaceuticals, Inc.	1.91%	215,190
19	MLYS	Mineralys Therapeutics, Inc.	1.76%	623,239
20	NBIX	Neurocrine Biosciences, Inc.	1.72%	135,273
21	SYRE	Spyre Therapeutics, Inc.	1.64%	396,281
22	IONS	Ionis Pharmaceuticals, Inc.	1.61%	205,400
23	CNTA	Centessa Pharmaceuticals plc	1.59%	614,165
24	LLY	Eli Lilly and Company	1.43%	14,071
25	BBIO	BridgeBio Pharma, Inc.	1.33%	207,858

Showing 25 of 95 holdings

Subscribe to see the full list

Activate Now

As of Feb 28, 2026